Key Takeaways
- • Wittington Investments, the private holding company of Canada's Weston family, has agreed to acquire Boots from Sycamore Partners and the Pessina family for total consideration of $8.9 billion, including assumed debt.
- • Fairfax Financial Holdings is partnering on the purchase, providing an equity commitment of up to approximately $2.3 billion and expecting to own 50% of Boots' equity at closing, while Wittington takes operational control.
- • Galen Weston, Wittington's chairman, will become chairman of Boots; Sycamore and the Pessina family retain Farmacias Benavides (Mexico) and Alliance Healthcare Deutschland.
- • CIBC and Morgan Stanley Senior Funding are arranging the acquisition financing, with UBS and Rothschild & Co. advising The Boots Group.
- • The transaction is subject to regulatory approvals and is expected to close in the first quarter of 2027, marking a notable exit for Sycamore's year-old standalone Boots carve-out.
Summary
Wittington Investments, the private holding company of Canada's Weston family, has signed a definitive agreement to acquire Boots from Sycamore Partners and the Pessina family for total consideration of $8.9 billion, including assumed debt, according to HedgeCo.Net. The perimeter includes Boots' retail operations in the U.K. and Ireland, Boots Opticians, the No7 Beauty Company, and its Thailand and franchised businesses.
Fairfax Financial Holdings is partnering with Wittington on the purchase. In a statement, Fairfax said it has entered into an equity commitment letter to provide up to approximately $2.3 billion toward the purchase price and expects to own 50% of Boots' equity once the transaction closes. Wittington will take operational control at closing, and Galen Weston, Wittington's chairman, will become chairman of Boots.
Sycamore Partners, alongside Stefano Pessina and his family, will retain The Boots Group's other interests, namely Farmacias Benavides in Mexico and German pharmaceutical wholesaler Alliance Healthcare Deutschland. On the financing side, CIBC and Morgan Stanley Senior Funding are lead arrangers of the acquisition debt, while UBS and Rothschild & Co. are lead financial advisors to The Boots Group.
The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in the first quarter of 2027. Sycamore re-established Boots as a standalone company roughly a year ago; managing director Stefan Kaluzny said the sale reflects the work the management team and more than 50,000 colleagues have done since then.
For private equity, the deal represents a notable exit route. A long-term family holding company and an insurance-backed investor are stepping in as buyers of a carve-out that a sponsor has spent a year separating. The structure also illustrates how sponsors can monetize a portion of a complex retail and wholesale group while retaining other assets, an approach that may appeal to firms holding conglomerates acquired at scale.
Fairfax Financial Holdings is partnering with Wittington on the purchase. In a statement, Fairfax said it has entered into an equity commitment letter to provide up to approximately $2.3 billion toward the purchase price and expects to own 50% of Boots' equity once the transaction closes. Wittington will take operational control at closing, and Galen Weston, Wittington's chairman, will become chairman of Boots.
Sycamore Partners, alongside Stefano Pessina and his family, will retain The Boots Group's other interests, namely Farmacias Benavides in Mexico and German pharmaceutical wholesaler Alliance Healthcare Deutschland. On the financing side, CIBC and Morgan Stanley Senior Funding are lead arrangers of the acquisition debt, while UBS and Rothschild & Co. are lead financial advisors to The Boots Group.
The transaction is subject to regulatory approvals and customary closing conditions and is expected to close in the first quarter of 2027. Sycamore re-established Boots as a standalone company roughly a year ago; managing director Stefan Kaluzny said the sale reflects the work the management team and more than 50,000 colleagues have done since then.
For private equity, the deal represents a notable exit route. A long-term family holding company and an insurance-backed investor are stepping in as buyers of a carve-out that a sponsor has spent a year separating. The structure also illustrates how sponsors can monetize a portion of a complex retail and wholesale group while retaining other assets, an approach that may appeal to firms holding conglomerates acquired at scale.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.